Drug Database
Back to search

Belgium· BE-AMP-SAM233055-00

OliClinomel N6-900

A lösungen zur parenteralen ernährung, kombinationen product containing tryptophan, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedOliClinomel N6-900ATCB05BA10REGISTER NO.BE-AMP-SAM233055-00PACKS LISTED4CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tryptophanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search lösungen zur parenteralen ernährung, kombinationen products by name

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tryptophan
Manufacturer
Baxter
Country
Belgium (BE)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

  • be_apb
    0773846
  • be_apb
    0773853
  • be_apb
    0773861
  • be_apb
    0773879

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lösungen zur parenteralen ernährung, kombinationen against other medicinesHow interaction checks work

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lösungen zur parenteralen ernährung, kombinationen in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lösungen zur parenteralen ernährung, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Ardeydorm, Ardeytropin
  • United Kingdom (Northern Ireland) · Optimax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b14d575f-9c0e-4c76-9fe0-8cee5e901f9f
GET /v1/drugs/b14d575f-9c0e-4c76-9fe0-8cee5e901f9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "OliClinomel N6-900",
  "name_fr": "OliClinomel N6-900",
  "name_nl": "OliClinomel N6-900",
  "amp_code": "SAM233055-00",
  "strengths": [
    "0.6100",
    "1.7000",
    "1.7000",
    "3.9100",
    "2.3100",
    "1.9000",
    "3.5000",
    "1.3600",
    "3.9100",
    "7.0400",
    "40.0000",
    "1.9000"
  ],
  "pack_count": 8,
  "substances": [
    "Tryptophan",
    "Serine",
    "Arginine",
    "Proline",
    "Phenylalanine",
    "Glycine",
    "Methionine",
    "Alanine",
    "Soyabean Oil + Olive Oil",
    "Isoleucine",
    "Histidine",
    "Valine",
    "Tyrosine",
    "Glucose Monohydrate",
    "Threonine",
    "Glucose Anhydrous",
    "Lysine",
    "Leucine",
    "Glycerol",
    "Sodium Hydroxide",
    "Sodium Oleate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Combinations",
  "authorisation_numbers": [
    "BE233055",
    "BE235085",
    "BE235121",
    "BE235164"
  ]
}
API referenceMCP serverPlans

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console